Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
Funder: National Institutes of Health
Due Dates: June 10, 2025 (New, Renewal, Resubmission, Revision; AIDS) | December 9, 2025 (New, Renewal, Resubmission, Revision; AIDS) | June 10, 2026 (New, Renewal, Resubmission, Revision; AIDS) | December 9, 2026 (New, Renewal, Resubmission, Revision; AIDS)
Funding Amounts: Phase I: up to $306,872 (1 year); Phase II: up to $2,045,816 (2 years); higher budgets possible with prior approval; typical awards: NIMHD up to $1M, NIDCR up to $250K, NCATS up to $1M, NIBIB up to $300K
Summary: Supports U.S. small businesses to develop, commercialize, and implement technologies that improve minority health and reduce health disparities in NIH-defined populations.
Key Information: Applications must explicitly address minority health or health disparities; only U.S. small businesses are eligible; clinical trials are optional; strict foreign disclosure and security requirements apply.